Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.
Nat Med
; 27(10): 1744-1751, 2021 10.
Article
in En
| MEDLINE
| ID: mdl-34331051
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Rheumatic Diseases
/
COVID-19 Vaccines
/
COVID-19
/
Antibodies, Viral
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Nat Med
Journal subject:
BIOLOGIA MOLECULAR
/
MEDICINA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: